Gian Lifecare Reports Positive Financial Results for Q1 FY25, Showing Strong Growth and Promising Future

Aug 16 2024 09:07 AM IST
share
Share Via
Gian Lifecare, a microcap healthcare services company, has reported a positive performance in the quarter ended March 2024, with a score of 17 compared to 4 in the previous quarter. The company's net sales, operating profit, and profitability have all shown significant growth, indicating a positive trend for the company in the near term.

Gian Lifecare, a microcap healthcare services company, has recently announced its financial results for the quarter ended March 2024. The company’s stock has been given a ‘Hold’ call by MarketsMOJO, a leading financial analysis platform.

According to the financial report, Gian Lifecare has shown a positive performance in the quarter, with a score of 17 compared to 4 in the previous quarter. This improvement can be attributed to the company’s strong financials in the first half of the year.


One of the key highlights of the financial report is the growth in net sales, which has increased by 26.36% year on year to reach Rs 8.39 crore. This indicates a positive sales trend in the near term for the company.


The company’s operating profit (PBDIT) for the quarter was the highest in the last five quarters, at Rs 3.04 crore. This shows a positive trend in the near term for the company’s operating profit.


Similarly, the profit before tax (PBT) less other income for the quarter was also the highest in the last five quarters, at Rs 2.84 crore. This indicates a positive trend in the near term for the company’s PBT.


Gian Lifecare’s profit after tax (PAT) for the quarter was also the highest in the last five quarters, at Rs 2.13 crore. This shows a positive trend in the near term for the company’s profitability.


The company’s earnings per share (EPS) for the quarter was also the highest in the last five quarters, at Rs 2.06. This indicates an increasing profitability for the company, creating higher earnings for its shareholders.


Overall, Gian Lifecare’s financial results for the quarter ended March 2024 have shown a positive trend, with strong growth in key financial metrics. This is a promising sign for the company and its investors.


{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News